Everything you should know about healthcare
Blog
Finally! Humira’s biosimilars also hit the us market!
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
How to Counter Drug Price Increases by Taking Advantage of Personal Importation and other Solutions
After wrapping up the 2023 enrollment, employers are now planning their next moves to mitigate the continuously growing healthcare costs impacting their plans. This is particularly true for pharmacy costs.
US indefensible high drug prices and the right to personal importation from secure countries
PhRMA, a Big Pharma lobbying group, released an advertising touting that drug prices were not fueling inflation. To prove it, they produce the graphic below.
Kff report on medical debt : what employers should know and do
100 million Americans, insured or not, are saddled with medical debt, a recent survey by Kaiser Family Foundation established.
US brand drug prices highest of developed countries
US brand drug prices highest of developed countries despite clouds of smoke from big pharma and the pbm oligopoly.
Part 1. All you need to know about PBMs
What employers and their consultants need to know to make the right decisions on their prescription drug plans.
Part 2. The ProBleMs with PBMs
What employers and their consultants need to know to make the right decisions on their prescription drug plans.
Part 3. How to choose your PBM
We could have titled this part: “Forget about rebates!”, but this would have been misleading: rebates are here to stay but many experts say the major part of it is now passed over to the plans.
Brussels principles on the sale of medicines over the internet
Care2Care International supports the Brussels Principles on the Sales of Medicines over the Internet, an initiative of the New-York based, non-profit organization, the Prescription Justice Institute.
Replay webinar featuring David Contorno and Christin Deacon
Health Benefits Strategy: Opportunities & Risks for the C-Suite.
Where to find information on Quality of Hospitals
Ranking Hospitals And Rating The Raters. In Part 1 We Introduced The 4 Top “Producers” Of Hospital Ratings.
It’s (still) the prices, stupid!
People interested in healthcare policy or insurance may remember this title from the late Uwe Reinhardt, a Princeton professor in Economy and expert in healthcare policy: ”it’s the prices, stupid!”, in reference to Bill Clinton’s campaign slogan: “it’s the economy, stupid!”.
